Open Essex

Alta Stomatology is a leading oral disease drug R&D company specializing in developing innovative medications targeting the epidermal growth factor receptor (EGFR) for the treatment of various oral diseases. With a team of experienced researchers and scientists, we are dedicated to improving the health and well-being of patients suffering from oral conditions through innovative drug development. Source from: EGFR